Tag: CREST-2
“Nothing but zeros”: Post-CREST-2, are innovative carotid stent designs set to...
"We've had changes in our EVAR devices, we've had changes in our CLTI , lower extremity, PAD intervention devices, so it only...
Guilherme Dabus
A rockstar inside and outside of the neurointerventional community, guitar aficionado Guilherme Dabus (Miami, USA) is the current president of the Society of NeuroInterventional...
Rethinking interventions for asymptomatic carotid stenosis
Caitlin Hicks (Baltimore, USA) reflects on CREST-2 following publication of the trial late last year.
After nearly a decade of enrolment and follow-up, CREST-2 provides...
CX 2026: Carotid trial debate highlights “key question” of cost-effectiveness
An audience poll asking, ‘What do we believe: ECST-2 or CREST-2?’ following a debate at the 2026 Charing Cross (CX) Symposium (21–23 April, London,...
Carotid revascularisation and medical management both fail to improve cognitive skills...
Restoring blood flow to the brain by treating carotid artery stenosis does not appear to improve patients’ cognitive skills, according to preliminary late-breaking science...
“Historical” CREST-2 data show reduced stroke risk with carotid stenting versus...
The international CREST-2 study has found that, for people with severe carotid artery narrowing who have not experienced recent stroke symptoms, a minimally invasive...
Increased market competition linked to higher odds of revascularisation among asymptomatic...
A vascular surgery research team with a growing reputation for its work investigating appropriateness in care in the peripheral vascular bed recently uncovered an...
